Paradigm Biopharmaceuticals Ltd: Paradigm Board Changes
Paradigm Biopharmaceuticals Ltd: Results of Meeting
Paradigm Biopharmaceuticals Ltd: 2023 AGM Company Update
Paradigm Biopharmaceuticals Ltd: PAR Pre-AGM Update
Paradigm Biopharmaceuticals Ltd: Addendum to Notice of Meeting
Paradigm Biopharmaceuticals Ltd: Notice of Annual General Meeting/Proxy Form
Paradigm Biopharmaceuticals Ltd: Resignation of Non-executive Director
Paradigm Biopharmaceuticals Ltd: iPPS Increases Cartilage Thickness in Phase 2 Trial
Paradigm Biopharmaceuticals Ltd: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
Paradigm Biopharmaceuticals Ltd: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
Paradigm Biopharmaceuticals Ltd: NWR Virtual Healthcare Conference Presentation
Paradigm Biopharmaceuticals Ltd: Paradigm Presentation to JP Morgan Healthcare Conference
Paradigm Biopharmaceuticals Ltd: Results of Meeting
Paradigm Biopharmaceuticals Ltd: Paradigm AGM Presentation
Paradigm Biopharmaceuticals Ltd: Notice of Annual General Meeting-Withdrawal of Resolutions
Paradigm Biopharmaceuticals Ltd: Paradigm CEO steps down & Appointment of MD
Paradigm Biopharmaceuticals Ltd: Bell Potter Virtual Healthcare Conference presentation
Paradigm Biopharmaceuticals Ltd: Notice of Annual General Meeting/Proxy Form
Paradigm Biopharmaceuticals Ltd: Paradigm Appoints Interim Company Secretary
Paradigm Biopharmaceuticals Ltd: Ineligible Shareholder Letter
No Data